Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (241-250 of 451) with videos related to

Pageof 46
Sort By:
Journal of Crohn'S & Colitis|December 18, 2014
Long-term efficacy and safety of azathioprine in ulcerative colitisRuchit Sood, Saqib Ansari, Tanya Clark, et al.
Diseases of the Colon and Rectum|December 8, 2009
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trialsAlexander C Ford, Nicholas J Talley, Eamonn M M Quigley, et al.
Alimentary Pharmacology & Therapeutics|August 8, 2022
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|September 28, 2022
Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' replyKeeley M Fairbrass, P John Hamlin, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2022
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United KingdomVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|February 15, 2022
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Canadian Journal of Gastroenterology & Hepatology|October 2, 2018
The Effect of Antidepressants on the Course of Inflammatory Bowel DiseaseBarry J Hall, P John Hamlin, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Journal of Crohn'S & Colitis|February 14, 2012
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experienceMichael B Sprakes, Alexander C Ford, Lisa Warren, et al.
Nature Reviews. Gastroenterology & Hepatology|April 25, 2025
Common misconceptions and controversies in the management of irritable bowel syndromeChristopher J Black, Carolina Olano, Eamonn M M Quigley, et al.
Pageof 46

Showing results (241-250 of 451) with videos related to

Sort By:
Pageof 46
Journal of Crohn'S & Colitis|December 18, 2014
Long-term efficacy and safety of azathioprine in ulcerative colitisRuchit Sood, Saqib Ansari, Tanya Clark, et al.
Diseases of the Colon and Rectum|December 8, 2009
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trialsAlexander C Ford, Nicholas J Talley, Eamonn M M Quigley, et al.
Alimentary Pharmacology & Therapeutics|August 8, 2022
Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|September 28, 2022
Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' replyKeeley M Fairbrass, P John Hamlin, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2022
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United KingdomVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|February 15, 2022
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Canadian Journal of Gastroenterology & Hepatology|October 2, 2018
The Effect of Antidepressants on the Course of Inflammatory Bowel DiseaseBarry J Hall, P John Hamlin, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|April 24, 2023
Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Journal of Crohn'S & Colitis|February 14, 2012
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experienceMichael B Sprakes, Alexander C Ford, Lisa Warren, et al.
Nature Reviews. Gastroenterology & Hepatology|April 25, 2025
Common misconceptions and controversies in the management of irritable bowel syndromeChristopher J Black, Carolina Olano, Eamonn M M Quigley, et al.
Pageof 46